BLU-263

CAS No. 2505078-08-8

BLU-263( —— )

Catalog No. M37619 CAS No. 2505078-08-8

BLU-263 is an investigational, potent, and selective oral small molecule inhibitor of KIT with sub-nanomolar potency against D816V-mutant KIT.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 141 In Stock
10MG 226 In Stock
25MG 434 In Stock
50MG 556 In Stock
100MG 798 In Stock
200MG 1070 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BLU-263
  • Note
    Research use only, not for human use.
  • Brief Description
    BLU-263 is an investigational, potent, and selective oral small molecule inhibitor of KIT with sub-nanomolar potency against D816V-mutant KIT.
  • Description
    Elenestinib (BLU-263) is a potent and orally active tyrosine kinase inhibitor. Elenestinib has the potential for the research of systemic mastocytosis (SM). Elenestinib inhibits KIT D816V with an IC50 value of 0.2 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    c-Kit
  • Recptor
    c-Kit
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2505078-08-8
  • Formula Weight
    528.58
  • Molecular Formula
    C27H29FN10O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (236.48 mM; Ultrasonic )
  • SMILES
    C[C@](N)(c1ccc(F)cc1)c1cnc(nc1)N1CCN(CC1)c1ncnn2cc(cc12)-c1cnn(CCO)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Dave N, et al. Safety and pharmacokinetics of BLU-263, a next-generation KIT inhibitor, in healthy volunteers[C]//Cancer Res (AACR Annual Meeting Abstracts). 2021, 122.
molnova catalog
related products
  • INCB024360 analogue

    IDO-IN-2 is an effective IDO1 inhibitor(IC50=10 nM).

  • Sarcosine

    Sarcosine is a competitive inhibitor of the type I glycine transporter (GlyT1) and an N-methyl-D-aspartate receptor (NMDAR) co-agonist.

  • Apatinib

    Apatinib is an orally bioavailable, selective VEGFR2 inhibitor with IC50 of 1 nM.